What's breaking now, across thousands of outlets.
The Centers for Medicare and Medicaid Services finalized a demonstration program aimed at lowering the prices of drugs in Medicare, but with significantly lower expected savings than previously projected. The
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
(MedPage Today) -- Orforglipron (Foundayo) was able to claim cardiovascular safety based on the ACHIEVE-4 trial, though heart benefits remain unproven.
Teens whose sleep length swings from night to night report more anxiety and sadness, a Fitbit-based study of 1,371 adolescents finds.
Researchers from the University of Bath have developed fluorescent molecular probes that can detect changes in glucose levels inside living animals, giving scientists new ways of visualizing sugar…
New research presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct.
New research presented at the Annual Meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy, Sept. 28–Oct.
